Your browser doesn't support javascript.
loading
Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
MacDougall, Conan; Canonica, Theora; Keh, Chris; P Phan, Binh An; Louie, Janice.
Affiliation
  • MacDougall C; Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, California, USA.
  • Canonica T; Department of Clinical Pharmacy, San Francisco Veterans' Affairs Medical Center, San Francisco, California, USA.
  • Keh C; Division of Infectious Disease, University of California, San Francisco, San Francisco, California, USA.
  • P Phan BA; Division of Cardiology, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.
  • Louie J; Division of Infectious Diseases, San Francisco Department of Public Health Tuberculosis Clinic, University of California, San Francisco, San Francisco, California, USA.
Pharmacotherapy ; 42(4): 343-361, 2022 04.
Article in En | MEDLINE | ID: mdl-35152432

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifamycins / Platelet Aggregation Inhibitors Type of study: Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharmacotherapy Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifamycins / Platelet Aggregation Inhibitors Type of study: Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharmacotherapy Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States